179 related articles for article (PubMed ID: 30335863)
61. Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signaling.
Lei JT; Mazumdar T; Martinez-Moczygemba M
J Biol Chem; 2011 Nov; 286(46):40091-103. PubMed ID: 21965659
[TBL] [Abstract][Full Text] [Related]
62. Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma.
Agarwal NK; Kim CH; Kunkalla K; Konno H; Tjendra Y; Kwon D; Blonska M; Kozloski GA; Moy VT; Verdun RE; Barber GN; Lossos IS; Vega F
Blood; 2016 Feb; 127(5):605-15. PubMed ID: 26603838
[TBL] [Abstract][Full Text] [Related]
63. Productive transcription of miR-124-3p by RelA and RNA polymerase II directs RIP1 ubiquitination-dependent apoptosis resistance during hypoxia.
Song YK; Hu BC; Xu L; Liu JQ; Chen X; Zheng Y; Chen MH; Wang JZ; Sun RH; Mo SJ
Exp Cell Res; 2019 May; 378(1):21-31. PubMed ID: 30844390
[TBL] [Abstract][Full Text] [Related]
64. Forced homo- and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth.
Suthaus J; Tillmann A; Lorenzen I; Bulanova E; Rose-John S; Scheller J
Mol Biol Cell; 2010 Aug; 21(15):2797-807. PubMed ID: 20554759
[TBL] [Abstract][Full Text] [Related]
65. E3 Ubiquitin Ligase RNF125 Activates Interleukin-36 Receptor Signaling and Contributes to Its Turnover.
Saha SS; Caviness G; Yi G; Raymond EL; Mbow ML; Kao CC
J Innate Immun; 2018; 10(1):56-69. PubMed ID: 29176319
[TBL] [Abstract][Full Text] [Related]
66. The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination.
Zhang Z; Li M; Lin P; Ren Y; He Y; Wang S; Xu Y; Cao B; Wang G; Moran MF; Mao X
J Biol Chem; 2023 May; 299(5):104675. PubMed ID: 37028761
[TBL] [Abstract][Full Text] [Related]
67. Roads to Stat3 Paved with Cadherins.
Adan H; Daniel J; Raptis L
Cells; 2022 Aug; 11(16):. PubMed ID: 36010614
[TBL] [Abstract][Full Text] [Related]
68. K63 ubiquitination in immune signaling.
Madiraju C; Novack JP; Reed JC; Matsuzawa SI
Trends Immunol; 2022 Feb; 43(2):148-162. PubMed ID: 35033428
[TBL] [Abstract][Full Text] [Related]
69. STAT3 Activation and Oncogenesis in Lymphoma.
Zhu F; Wang KB; Rui L
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861597
[TBL] [Abstract][Full Text] [Related]
70. E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.
Yang L; Jin L; Ke Y; Fan X; Zhang T; Zhang C; Bian H; Wang G
J Invest Dermatol; 2018 Dec; 138(12):2568-2577. PubMed ID: 29859926
[TBL] [Abstract][Full Text] [Related]
71. The Carcinogen Cadmium Activates Lysine 63 (K63)-Linked Ubiquitin-Dependent Signaling and Inhibits Selective Autophagy.
Chargui A; Belaid A; Ndiaye PD; Imbert V; Samson M; Guigonis JM; Tauc M; Peyron JF; Poujeol P; Brest P; Hofman P; Mograbi B
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065348
[TBL] [Abstract][Full Text] [Related]
72. Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-beta.
MacPartlin M; Zeng SX; Lu H
J Biol Chem; 2008 Jun; 283(23):15754-61. PubMed ID: 18411264
[TBL] [Abstract][Full Text] [Related]
73. Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K; Pilati C; Couchy G; Calderaro J; Bioulac-Sage P; Bacq Y; Paradis V; Leteurtre E; Sturm N; Ramos J; Guettier C; Bardier-Dupas A; Boulai A; Wendum D; Selves J; Izard T; Nault JC; Zucman-Rossi J
Oncoimmunology; 2013 Dec; 2(12):e27090. PubMed ID: 24501689
[TBL] [Abstract][Full Text] [Related]
74. Intracellular signaling prevents effective blockade of oncogenic gp130 mutants by neutralizing antibodies.
Rinis N; Küster A; Schmitz-Van de Leur H; Mohr A; Müller-Newen G
Cell Commun Signal; 2014 Mar; 12():14. PubMed ID: 24612692
[TBL] [Abstract][Full Text] [Related]
75. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination.
Zhu G; Herlyn M; Yang X
Nat Cell Biol; 2021 Sep; 23(9):978-991. PubMed ID: 34497368
[TBL] [Abstract][Full Text] [Related]
76. IKKβ/NFκBp65 activated by interleukin-13 targets the autophagy-related genes LC3B and beclin 1 in fibroblasts co-cultured with breast cancer cells.
Li WL; Xiong LX; Shi XY; Xiao L; Qi GY; Meng C
Exp Ther Med; 2016 Apr; 11(4):1259-1264. PubMed ID: 27073433
[TBL] [Abstract][Full Text] [Related]
77. IL-23 and the Tumor Microenvironment.
Subhadarshani S; Yusuf N; Elmets CA
Adv Exp Med Biol; 2021; 1290():89-98. PubMed ID: 33559857
[TBL] [Abstract][Full Text] [Related]
78. IKKβ is an IRF5 kinase that instigates inflammation.
Ren J; Chen X; Chen ZJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17438-43. PubMed ID: 25326420
[TBL] [Abstract][Full Text] [Related]
79. IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment.
Manore SG; Doheny DL; Wong GL; Lo HW
Front Oncol; 2022; 12():866014. PubMed ID: 35371975
[TBL] [Abstract][Full Text] [Related]
80. Inflammation and cancer: IL-6 and STAT3 complete the link.
Bromberg J; Wang TC
Cancer Cell; 2009 Feb; 15(2):79-80. PubMed ID: 19185839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
